NM_005629.4:c.1714G>A
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BS2
This summary comes from the ClinGen Evidence Repository: The NM_005629.4:c.1714G>A variant in SLC6A8 is a missense variant predicted to cause the substitution of a valine by a methionine at amino acid position 572 (p.Val572Met). To our knowledge, this variant has not been reported in the literature and no functional studies are available. In gnomAD v4.1.0, the highest population minor allele frequency MAF) is 0.0000369 (33/894244 alleles, 12 hemizygotes) in the European (Non-Finnish) population. This MAF is greater than the ClinGen CCDS VCEP’s threshold for PM2_Supporting (<0.00002) but less than the ClinGen CCDS VCEP’s threshold for BS1 (>0.0002), such that neither of these criteria are met. There are 14 hemizygotes in gnomAD v4.1.0. (12 in the European non-Finnish, one in the "other" and one in the S. Asian population) (BS2). The computational predictor REVEL gives a score of 0.689, which is less than the ClinGen CCDS VCEP’s threshold for PP3 (>0.75) but greater than the ClinGen CCDS VCEP’s threshold for BP4 (<0.2), such that neither of these criteria are met. There is a ClinVar entry for this variant (Variation ID: 449188). Due to the presence of 14 hemizygotes in gnomAD v4.1.0, the consensus of the CCDS VCEP is to classify this variant as likely benign for creatine transporter deficiency, a severe, pediatric onset neurodevelopmental disorder. SLC6A8-specific ACMG/AMP criteria applied, as specified by the ClinGen CCDS VCEP (Specifications Version 1.1.0): BS2.(Classification approved by the ClinGen Cerebral Creatine Deficiency Syndromes Variant Curation Expert Panel on March 13, 2025) LINK:https://erepo.genome.network/evrepo/ui/classification/CA10549625/MONDO:0010305/027
Frequency
Consequence
NM_005629.4 missense
Scores
Clinical Significance
Conservation
Publications
- creatine transporter deficiencyInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, ClinGen, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_005629.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SLC6A8 | NM_005629.4 | MANE Select | c.1714G>A | p.Val572Met | missense | Exon 12 of 13 | NP_005620.1 | ||
| SLC6A8 | NM_001142805.2 | c.1684G>A | p.Val562Met | missense | Exon 12 of 13 | NP_001136277.1 | |||
| SLC6A8 | NM_001142806.1 | c.1369G>A | p.Val457Met | missense | Exon 12 of 13 | NP_001136278.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SLC6A8 | ENST00000253122.10 | TSL:1 MANE Select | c.1714G>A | p.Val572Met | missense | Exon 12 of 13 | ENSP00000253122.5 | ||
| SLC6A8 | ENST00000430077.6 | TSL:2 | c.1369G>A | p.Val457Met | missense | Exon 12 of 13 | ENSP00000403041.2 | ||
| SLC6A8 | ENST00000485324.1 | TSL:2 | n.2021G>A | non_coding_transcript_exon | Exon 5 of 6 |
Frequencies
GnomAD3 genomes Cov.: 25
GnomAD2 exomes AF: 0.0000397 AC: 7AN: 176255 AF XY: 0.0000481 show subpopulations
GnomAD4 exome AF: 0.0000393 AC: 43AN: 1094605Hom.: 0 Cov.: 38 AF XY: 0.0000388 AC XY: 14AN XY: 360917 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 25
ClinVar
ClinVar submissions as Germline
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at